Searched for
LEVETIRACETAM INJECTION
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...
- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring ...
- Dr Reddy's, Lupin recall products in US due to labelling, manufacturing errors: USFDADr. Reddy's Laboratories and Lupin are recalling products in the US due to labeling and manufacturing issues. Dr. Reddy's is recalling an a...
- Dr Reddy’s shares in focus after recall of mislabelled Levetiracetam injection in USThe potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, respiratory depression...
- Stocks in news: Dr Reddy’s, Shilpa Medicare, Voltas, TCS, Tata MotorsDomestic markets closed slightly lower last week amid mixed global cues. Shares of Dr Reddy’s, Shilpa Medicare, and Tata Motors will be in ...
- Dr. Reddy’s recalls mislabelled Levetiracetam injection in the US; patients likely to experience 'adverse' eventsDr. Reddy’s Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which could result in ...
- Mapping the market: IT stocks shine on weak rupee; select smallcaps soarThe market behaviour on Monday, which was similar to what we saw many times last week, simply meant equity investors on Dalal Street have n...
- Aurobindo Pharma surges 5% on getting USFDA approval for LevetiracetamAurobindo's Levetiracetam in Sodium Chloride Injection is a generic equivalent of HQ Specialty Pharma Corp's Levetiracetam in Sodium Chlori...
- Mapping the market: Dalal Street had a dull day; here is who won and who lostBesides money policy expectations, what probably kept investors on tenterhooks was the Finance Minister’s meeting with the chiefs of PSBs d...
- Jubilant Lifesciences surges as USFDA gives final nod for epilepsy drugShares of Jubilant Lifesciences surged 6 per cent in trade on Monday after the firm received final approval for its generic drug from USFDA.
- Sensex snaps 3-day winning streak to end lower ahead of RBI policy meetThe lack of domestic triggers and an opportunity for re-allocation of portfolios post the end of the March quarter earnings also weighed on...
- Fifteen stocks in focus in Monday morning tradeThe Indian market is expected to open flat. Here is a list of top fifteen stocks that are likely to be in focus today.
- Aurobindo gets USFDA nod for epilepsy, arthritis drugsLevetiracetam injection is used for treatment of partial onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, a...
- Shakers on D-Street: TTK Prestige, Aurobindo, Sun PharmaICICI Securities has initiated coverage of TTK Prestige with an ‘Add’ rating and a price target of Rs 3,900.
- Sun Pharma receives USFDA nod for anti-anxiety drugSun Pharmaceutical Industries today said that it has received the US Food and Drug Administration's nod to market a generic version of alpr...
- Sun Pharma gets US regulator's nod for epilepsy drugDrug maker Sun Pharmaceutical Industries on Thursday said it has received the US health regulator's nod for marketing a generic version of ...
Load More
